BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31456025)

  • 1. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: an experimental study.
    Tavernier C; Passot G; Vassal O; Allaouchiche B; Decullier E; Bakrin N; Alyami M; Davigo A; Bonnet JM; Louzier V; Paquet C; Glehen O; Kepenekian V
    Surg Endosc; 2020 Jul; 34(7):2939-2946. PubMed ID: 31456025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Alyami M; Mercier F; Siebert M; Bonnot PE; Laplace N; Villeneuve L; Passot G; Glehen O; Bakrin N; Kepenekian V
    Eur J Surg Oncol; 2021 Jan; 47(1):128-133. PubMed ID: 31253545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer.
    Gruner M; Chambers LM; Yao M; Chichura A; Morton M; Costales AB; Horowitz M; Rose PG; Debernardo R; Michener CM
    Gynecol Oncol; 2021 Sep; 162(3):645-651. PubMed ID: 34247768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model.
    Davigo A; Passot G; Vassal O; Bost M; Tavernier C; Decullier E; Bakrin N; Alyami M; Bonnet JM; Louzier V; Paquet C; Allaouchiche B; Glehen O; Kepenekian V
    Int J Hyperthermia; 2020; 37(1):144-150. PubMed ID: 32003300
    [No Abstract]   [Full Text] [Related]  

  • 6. Anastomotic leakage after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer.
    Feenstra TM; Verberne CJ; Kok NF; Aalbers AGJ
    Eur J Surg Oncol; 2022 Dec; 48(12):2460-2466. PubMed ID: 36096855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Clinical Safety and Feasibility Data of Whole-body Hyperthermia Pressurized Intraperitoneal Aerosol Chemotherapy (WBH-PIPAC) for Peritoneal Surface Malignancies.
    Kockelmann F; Giger-Pabst U; Ouaissi M; Bucur P; Barbey S; VON Ardenne A; Zieren J
    Anticancer Res; 2024 Jul; 44(7):3043-3050. PubMed ID: 38925817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal anastomosis during cytoreductive radical surgery in patients with peritoneal surface malignancies. Validation of a new technique (without stoma) to prevent anastomosis leakage in more than 1000 procedures.
    Barrios P; Ramos I; Crusellas O; Sabia D; Mompart S; Martín-Baranera M
    Clin Transl Oncol; 2021 Jun; 23(6):1201-1209. PubMed ID: 33393053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)?
    Ametsbichler P; Böhlandt A; Nowak D; Schierl R
    Eur J Surg Oncol; 2018 Nov; 44(11):1793-1799. PubMed ID: 29871821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Girshally R; Demtröder C; Albayrak N; Zieren J; Tempfer C; Reymond MA
    World J Surg Oncol; 2016 Sep; 14(1):253. PubMed ID: 27678344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes
    Acs M; Halmy L; Isgandarova S; Blaj S; Gerken M; Hormann B; Piso P
    Anticancer Res; 2022 Feb; 42(2):1019-1029. PubMed ID: 35093903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and predictive value of blood lactate levels during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a comparative analysis.
    Tonello M; Barina A; Turchet F; De Simoni O; Alfieri R; Franzato B; Gruppo M; Dengo B; Deffenu D; Di Pasquale D; Fiore T; Pietropaoli C; Munaron S; Zanardo G; Sommariva A; Pilati P
    Updates Surg; 2021 Feb; 73(1):313-319. PubMed ID: 33146888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PIPAC and HIPEC-competing or supplementary therapeutic procedures for peritoneal metastases].
    Leebmann H; Piso P
    Chirurg; 2018 Sep; 89(9):693-698. PubMed ID: 29931380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer.
    Marrelli D; Petrioli R; Cassetti D; D'Ignazio A; Marsili S; Mazzei MA; Lazzi S; Roviello F
    Surg Oncol; 2021 Jun; 37():101523. PubMed ID: 33545658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.
    Weinreich J; Struller F; Sautkin I; Giuashvili S; Reymond M; Königsrainer A; Schott TC
    Invest New Drugs; 2019 Jun; 37(3):415-423. PubMed ID: 30019100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
    Quénet F; Elias D; Roca L; Goéré D; Ghouti L; Pocard M; Facy O; Arvieux C; Lorimier G; Pezet D; Marchal F; Loi V; Meeus P; Juzyna B; de Forges H; Paineau J; Glehen O;
    Lancet Oncol; 2021 Feb; 22(2):256-266. PubMed ID: 33476595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
    Dumont F; Senellart H; Pein F; Campion L; Glehen O; Goere D; Pocard M; Thibaudeau E
    Pleura Peritoneum; 2018 Sep; 3(3):20180120. PubMed ID: 30911664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and Safety of Laparoscopic D2 Gastrectomy in Combination with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Gastric Cancer at High Risk of Recurrence-The PIPAC-OPC4 Study.
    Graversen M; Rouvelas I; Ainsworth AP; Bjarnesen AP; Detlefsen S; Ellebaek SB; Fristrup CW; Liljefors MG; Lundell L; Nilsson M; Pfeiffer P; Tarpgaard LS; Tsekrekos A; Mortensen MB
    Ann Surg Oncol; 2023 Jul; 30(7):4433-4441. PubMed ID: 36867174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.